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ABSTRACT
EFFECTS OF HEAT AND MOISTURE EXCHANGERS DESIGNED TO ALLOW AEROSOL
DELIVERY ON AIRFLOW RESISTANCE AND AEROSOL DEPOSITION
By
William Sonny Bowers
Introduction: Several problems arise when HMEs are used while giving aerosolized
medication including increased airway resistance (Raw) or the need to open the ventilator circuit.
Recently, heat and moisture exchangers designed to allow aerosol delivery (HME-AD) have
been developed to solve this problem, but no tests have been performed to confirm their
effectiveness. The purpose of this study is to evaluate the effect of HME-ADs on aerosol
deposition and Raw.
Methods: An in-vitro lung model consisting of an 8.0 mm ID endotracheal tube (ETT)
connected to a standard ventilator circuit and ventilator was connected to a rubber test lung via
cascade humidifier set to deliver 37˚C and 100% relative humidity. The ventilator settings were
as follows: Vt 450 ml, RR 20/min, PIF 50 L/min, PEEP 5 cm H2O, and I:E ratio 1:2. HME-ADs
used in this study include Circuvent HME/HCH bypass (Smiths-Medical, Keene, NH), Gibeck
Humid-Flo HME (Hudson RCI, Arlington Heights, IL), and Airlife BHME (Carefusion, San
Diego, CA). As a control, albuterol sulfate (2.5 mg/3mL) was delivered with a vibrating mesh
nebulizer (Aeroneb Solo, Aerogen Inc) placed at the wye without any HME-AD in the circuit.
Then, the aerosol and HME configurations of each HME-AD were tested by measuring pre-post
Raw and aerosol deposition at the end of each run. Each condition was repeated in triplicate
(n=3). Aerosol deposition between the aerosol and HME configurations of each HME-AD was
compared with a series of student t-tests. Then, differences both in aerosol deposition and in
airway resistance among the HME-ADs were analyzed using one-way analysis of variance
(ANOVA). Significance was determined as p<0.05.
Results: Raw increased after each albuterol treatment with every HME-AD. In the
aerosol configuration, the Circuvent and Humid-Flo delivered significantly less aerosol
compared to the control (p=.004 and p=.002, respectively), while there was no significant
difference on aerosol delivery between the Airlife and the control (p=.084). The Airlife gave the
highest aerosol deposition which was not significantly different than control (p=.084). When
aerosol delivery between the HME and aerosol configurations in each HME-AD was compared,
aerosol deposition with the Humid-Flo was not significantly different (p=.078) but both the
Airlife and the Circuvent showed a statistically significant reduction in aerosol deposition with
the HME configuration (p=.002 and p=.005).
Conclusions: Aerosol delivery and Raw with each HME-AD differ in simulated
mechanically ventilated patients. Further studies are needed to determine the effectiveness of
these devices over time and with different aerosol generating devices.

TABLE OF CONTENTS

List of Tables
List of Figures
Abbreviations

Page
iv
v
vi

Chapter
I. INTRODUCTION
Significance
Purpose
Research Questions

1
1
3
3

II. REVIEW OF THE LITERATURE

4

III. METHODS
Instruments
Data Collection
Data Analysis

17
17
19
21

IV. RESULTS

22

V. DISCUSSION
Observations
Literature Comparison
Limitations
Conclusion

27
27
30
31
32

References

33

ii

LIST OF TABLES

Tables

Page

1.

Mean airway resistance before and after albuterol treatment

22

2.

Comparison of aerosol deposition

25

iii

LIST OF FIGURES

Figures

Page

1.

Diagram of lung model and ventilator setup

17

2.

Photographs of The HME-ADs

19

3.

Airway resistance in the aerosol configuration

23

4.

Airway resistance in the HME configuration

24

5.

Comparison of aerosol deposition

26

iv

ABBREVIATIONS
HME
PEEP
HME-AD
COPD
PEEPi
FRC
CPAP
ICU
M1
M2
WOB
HMEF
ETT
BAN
VMN
ANOVA

Heat and moisture exchanger
Positive end expiratory pressure
Heat and moisture exchanger designed to allow aerosol delivery
Chronic obstructive pulmonary disease
Intrinsic Positive end expiratory pressure
Functional residual capacity
Continuous positive airway pressure
Intensive care unit
Icor Mediflux 1
Icor Mediflux 2
Work of breathing
Heat and moisture exchanger with filter
Endotracheal tube
Breath actuated nebulizer
Vibrating mesh nebulizer
Analysis of variance

v

CHAPTER I
INTRODUCTION
During mechanical ventilation, airway humidification is essential for pulmonary function.
In normal breathing without intubation, air is warmed to 37° C and humidified to 100% relative
humidity, (Shelly, Lloyd, & Park, 1988). While the upper airway is responsible for this function
in normal spontaneously breathing individuals, it is bypassed during mechanical ventilation.
Therefore, heat and humidity must be provided for the patient. Traditionally, this has been
accomplished via a heated humidifier. Recently, heat and moisture exchangers (HME), also
called artificial noses, are being used more frequently for this purpose. In a mechanically
ventilated patient, an HME is placed in the ventilator circuit between the endotracheal tube and
wye piece, and collects heat and moisture from a patient’s expired breath, which is used to warm
and humidify the subsequent inspired breath.
HMEs offer several benefits over heated humidifiers. HMEs are inexpensive, do not
require electrical power, and since there is no need to refill water as in heated humidifiers, HMEs
are simpler and more cost efficient to maintain (Ploysongsang, Branson, Rashkin, & Hurst,
1988). In fact, studies have shown that leaving HMEs in the ventilator circuit for extended
lengths up to 5-7 days is safe and does not increase the risk of ventilator associated pneumonia
(Davis, et al., 2000; Thomachot, et al., 2002). Also, some HMEs offer microbial filtering
capabilities, which were shown to decrease colonization of the ventilator circuit to 12%, as
opposed to 68% in heated humidifiers (Boots, Howe, George, Harris, & Faoagali, 1997).
Clearly, HMEs are an interesting alternative to heated humidifiers.
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Despite the benefits of HMEs, there are drawbacks to their use. Inclusion of HME in a
ventilator circuit has been shown to increase airflow resistance (Chiaranda, et al., 1993; Hart,
2009; Ploysongsang, et al., 1988). However, the clinical significance of this resistance is
negligible. Particularly, the administration of aerosolized medication creates a dilemma.
Introduction of aerosolized medication into the HME has been shown to appreciably increase
resistance (Hart, et al., 2009). One solution is to remove the HME when giving aerosol
treatments. However, in order to remove the HME, the ventilator circuit must be disconnected,
which entails its own problems. Disconnection causes a loss of positive end expiratory pressure
(PEEP), which leads to derecruitment of lung units. A further risk associated with disconnection
is the opening of the circuit to possible infection. Consequently, careful consideration must be
taken for which method of humidification should be used for mechanically ventilated patients
needing aerosolized therapy.
To resolve this quandary associated with aerosols and HME use, specialty HMEs
designed for aerosol delivery (HME-AD) have recently become available. These HME-ADs
operate by turning a lever or dial to position the device so aerosol can bypass the HME portion of
the device (aerosol configuration). A second turn of the lever or dial redirects the air through the
HME (HME configuration). With these devices, aerosol can be delivered without disconnecting
the ventilator circuit.
Because these devices are fairly new, there is little literature to support their use. As
HME-ADs must provide a separate route for aerosol to bypass the HME, it is possible that they
would cause greater impaction of the aerosol causing it to fall out of suspension before it enters
the respiratory tract. In a preliminary report from Brady and Hess (2004), one HME-AD was
2

shown to decrease aerosol deposition by as much as 40% . Another concern is if the aerosolized
medication enters the HME division, it may contribute to resistance. Nevertheless, early
evidence suggests this is not the case (Badescu, Volsko, & Chatburn, 2007; Branson &
Johannigman, 2004). Therefore, the purpose of this study is to evaluate the effectiveness of
HME-ADs designed to allow aerosol delivery on aerosol deposition and airway resistance.
These novel HMEs offer a useful solution to allow the delivery of aerosol with the use of
HME but it is important to understand the function of these devices before their use. With the
increasing cost of healthcare, answering these questions will allow the healthcare provider to
make the best decision about which humidification device to choose.
Therefore the questions asked during this study include:
1.

How is deposition of aerosolized albuterol affected when passed through HME-ADs
in the aerosol and HME configurations?

2. How is resistance affected when giving aerosolized albuterol through HME-ADs
when in the aerosol and HME configurations?

3

CHAPTER II
REVIEW OF LITERATURE
A review of literature was conducted to develop a better understanding of the influence of
HMEs on airflow resistance and delivery of aerosols during mechanical ventilation. The studies
reviewed in this chapter were derived from searches of bibliographic databases including
PubMed, CINAHL, Web of Science, Science Direct, Ebscohost. Further, a search was
completed via Respiratory Care journal. The search terms used include the following: heat and
moisture exchanger, nebulizer, vibrating mesh nebulizer, and mechanical ventilation. Both in
vivo and in vitro studies were included in this chapter. Articles not written in English were
excluded, and only articles pertaining to adults were used. Once these articles were obtained, the
reference lists were reviewed to ensure no relevant articles were excluded. A total of 24 articles
were chosen for review. This review of literature will explore resistance through an HME,
aerosol delivery during mechanical ventilation, vibrating mesh nebulizers during mechanical
ventilation, and HMEs designed to allow aerosol delivery.
Resistance through a Heat and Moisture Exchanger
In a benchmark study on added airflow resistance associated with HMEs, Ploysongsang,
et al. (1988) tested six common HMEs (Portex Hygroscopic Humid-Vent-1, Siemens Servo
Humidifier 150, Siemens Elema Ventilator Systems, Siemens Servo Humidifier 151, National
Catheter Corporation Humidifier, Engström Edith Humidifier, and the Pall Humidifier) in a
ventilator circuit with a water bath heated to 37°C connected to a bench top lung model. Their
research showed that all six HMEs tested increased air flow resistance. Further, the resistance
increased with increased flow rates and longer duration of use. Extended use of the HME allows
the increased moisture content in the HME to clog small pores. The authors conclude that HMEs
4

should be used cautiously in critically ill and weak patients because the extra resistance could
lead to fatigue or ventilatory failure.
Another in vitro study conducted by Hart (2009) investigated the effects of added
humidity with an HME in a ventilator circuit. The ventilator circuit was kept at 37°C with 100%
relative humidity. Thirty minutes after the HME was placed in the circuit, the resistance
increased from 8.99 cm H2O/l/sec to 9.23 cm H2O/l/sec and the weight of the HME increased
from 27.92 g to 28.62 g. Neither of these findings was statistically significant. This research
illustrates that an HME added to a ventilator circuit for a short time does not have a profound
effect on resistance.
The implications of increased resistance were unknown for chronic obstructive
pulmonary disease (COPD) patients, but increased expiratory resistance from an HME has the
potential to affect intrinsic PEEP (PEEPi). To discover the consequences of this resistance in
vivo, Conti, et al. (1990) tested the effects of three different HMEs on 10 COPD patients
undergoing mechanical ventilation. The research showed no significant increases in PEEPi or
functional residual capacity (FRC) in any of the patients tested after one or 12 hours. The
authors conclude that the amount of resistance to airflow through an HME over 12 hours is not
significant during mechanical ventilation of COPD patients.
To further elucidate the effects of increased resistance by adding HME into ventilator
circuits in vivo, Chiaranda, et al. (1993) tested the effectiveness of HMEs on 96 patients who
were intubated and receiving mechanical ventilation. Hygroscopic HMEs were used to provide
warmth and humidity to the airway during a 24 hour test period. The results showed the mean
resistance was increased by 0.5 hPa/l*s and based on subjective scoring there was no significant
change in bronchial secretion characteristics. The authors conclude that use of HMEs is
5

effective in heating and humidifying inspired air, and although the HMEs do increase airflow
resistance, the increase is only slight. Nevertheless, caution should be used in patients with thick
secretions.
Another in vivo study examined the effects of HMEs on the ventilatory pattern and
respiratory mechanics in patients. Natalini, Bardini, Latronico, and Candiani (1994) conducted a
study on nine patients in the intensive care unit (ICU) who were spontaneously breathing with
continuous positive airway pressure (CPAP). The patients had humidification added by active
humidification, or one of two HMEs: the Icor Mediflux 1(M1) or Icor Mediflux 2 (M2). Each
apparatus was administered for one hour. At the end of the study, they found that the tidal
volume was increased in the M1, which has the most mechanical deadspace, but remained the
same with the active humidifier. The M1 also increased work of breathing, but was clinically
well tolerated. The study also showed no differences in PEEPi or airway resistance between any
of the groups. The study illustrated that HMEs did not change resistance in spontaneously
breathing patients, but smaller HMEs are preferable due to the increased work of breathing
associated with increased deadspace.
Manthous and Schmidt (1994) conducted a similar study to determine how HMEs affect
resistance in the ventilator circuit over time in vivo. Their study involved 23 patients who were
mechanically ventilated in assist control mode with the Siemens 153 condenser humidifier.
Resistance was measured when the HME was first placed in the circuit (new) and at a point less
than 24 hours later (old). The findings showed that the old HME caused a 64% increase in the
circuit compared to no humidifier. The authors also found an increase in mean resistive pressure
from 4.8 to 6.3 cm H2O between new and old HMEs. In five patients, the same HME was
measured initially and 24 hours after being placed in the circuit. These HMEs showed a mean
6

increase in resistance from 3.4 to 7.0 cm H2O—a two-fold increase. The authors conclude that
HMEs may add clinically significant resistance with time, which could lead to unnecessary
therapies or slow ventilator weaning.
Increase in resistance in the ventilator circuit, as noted in studies above, may lead to
increased work of breathing (WOB). Pelosi, et al (1996) examined the effects of adding an
HME to a ventilator circuit on a patient’s WOB. The study was conducted on 14 patients
admitted to the ICU for acute respiratory failure and ventilated with pressure support ventilation.
Each patient was provided humidity by both heated humidifier and HME, each for 90 minutes.
The authors found that the HME increased minute ventilation as a result of increased tidal
volume from the added deadspace associated with using an HME. Further, patients using the
HME showed increased WOB and PEEPi. In fact 5 of 14 patients appeared visibly fatigued
during HME breathing trial. The authors attribute the increase in WOB and PEEPi to the
increased resistance from HME, and note WOB can be attenuated by increasing pressure
support.
The mechanical effects that lead to the increased work of breathing found by Pelosi et al.
(1996) include resistance and dead space. To expand the knowledge on these mechanical effects
of HMEs, Iotti, et al. (1997) compared the effects of a heated humidifier, HME without filtering
function, and HME with filter (HMEF) on 10 patients receiving pressure support mechanical
ventilation. The authors found that minute ventilation, dead space, airflow resistance, and work
of breathing were all increased with the HME devices. In the patients using HME devices, an
increase in pressure support was required to maintain alveolar ventilation. HMEF increased
these values further than HME without filter, and also caused an increase in PEEPi. The authors
concluded that the use of HMEs should be monitored carefully when used clinically.
7

The resistive effects of an HME could be further exacerbated by the accumulation of
excess condensation or patient secretions within HMEs which may lead to increased work of
breathing and occlusion of the circuit. To test the effect of accumulation of secretions and
condensation within HMEs, Morgan-Hughes, Mills, and Northwood (2001) added 0.9% saline to
the patient end of three different HMEFs. Resistance of the HMEF across a BiPAP circuit was
measured with each 5 ml saline until the maximum volume that the HMEF could hold was
attained. The results showed that addition of saline resulted in a “tampon” effect which
significantly increases bi-directional airflow resistance in all three HMEFs. This increase was
most significant in the composite designs that typically provide highest humidity. This research
shows that HMEs should be monitored closely by the patient’s caretakers for the presence of
secretions or buildup of condensation.
Expanding the research of Morgan-Hughes, et al. (2001), Turnbull, Fisher, Mills, and
Morgan-Hughes (2005) tested fourteen different HMEFs in the manner previously described by
Morgan-Hughes. These HMEFs fell into three categories: HMEs made of polyurethane foam or
corrugated cellulose fiber, both with polypropylene fiber filters, or ceramic pleated membrane
HMEF. An important variable that was included is the concealment volume—the amount of
liquid the HME may hold before excess moisture is visible on the HMEF. This signifies the
volume the HME may contain before becoming visible and the health practitioner would replace
it. The pleated membrane HMEF did not absorb saline and thus had a low concealment volume
and low resistance. However, these HMEF provides poor moisture output. Polyurethane foam,
showed a moderate concealment volume with moderate increase in resistance, and corrugated
cellulose fiber HMEF had a high concealment volume with the highest resistance. The authors
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conclude the optimal design should provide the most humidification with the least concealment
volume and resistance.
In addition to adding resistance via airflow through the HME, HMEs may also add
resistance from the narrowing of the lumen of an endotracheal tube (ETT) as a result of increased
secretions. Adherence of secretions forming a biofilm is a known phenomenon, but it is
unknown if use of an HME for greater than 48 hours would increase this biofilm more than a
heated humidifier. In a study by Villafane, et al. (1996), 23 patients who were mechanically
ventilated were randomly assigned to receive humidification by hygroscopic HME, hydrophobic
HME, or heated humidifier. Their results showed that after 48 hours the group with hydrophobic
HME had a significantly greater reduction in inner ETT diameter, while there were no significant
differences between the hygroscopic HME and heated humidifier. The authors state that since
hygroscopic HMEs are more effective at providing humidification, the less humidified secretions
are the cause of ETT narrowing. Based on their results, they conclude that hydrophobic HMEs
should be avoided for extended use, and that hygroscopic HMEs are good alternatives to heated
humidifiers.
Davis, et al. (2000) also examined the use of HMEs on patients for up to five days. The
patients in the study were receiving mechanical ventilation and designated to one of three
groups: one group used a hygroscopic HME designed for short term use changed every 24 hours
(HHME-24), the second used hygroscopic HME designed for short term use changed every 120
hours (HHME-120), and the third used a hydrophobic HME designed for long term use changed
every 120 hours (HME-120). The authors found that there was no difference in bacterial
colonization or nosocomial pneumonia between the groups. During use of the HME there was
9

no clinical significance in change in airway resistance from day 1 to 5. The authors conclude
that long-term as well as short-term use HMEs can safely be used for up to 5 days, which will
result in savings for hospitals.
Building off the Villafane, et al. study (1996), Jaber, et al. (2004) investigated how HME
use impacted ETT patency and resistance when used for longer than a week . Patients in this
study received humidification with either a hydrophobic-hygroscopic HME or heated humidifier
for a mean duration of 10 days. At the midpoint of the study (mean-5 days) there were no
significant differences in ETT volume or resistance, which agrees with the findings of Villafane,
et al. (1996) and Davis et al. (2000). However, at the end point of the study resistance was
significantly increased and ETT volume was significantly decreased in the HME group. Further,
the mean daily resistance increased in the HME group. The authors concluded that for short
periods of mechanical ventilation HMEs are safe, but when providing humidification for longer
than a week the risk of ETT occlusion and added resistance increases, and a heated humidifier
should be considered.
Aerosol Deposition during Mechanical Ventilation
MacIntyre, et al. (1985) conducted a benchmark study to determine the effectiveness of
aerosol delivery during mechanical ventilation. Seven clinically stable patients were intubated
and mechanically ventilated for acute respiratory failure and three nonintubated volunteers were
given radiolabeled aerosol via jet nebulizer. Imaging revealed that in the mechanically ventilated
patients, 2.9% of the aerosol reached the lung parenchyma, and tracheal deposition was increased
versus nonintubated patients. In a second part of the study, 15 intubated patients and 20
nonintubated patients were given metaproteronal via jet nebulizer to compare physiologic
10

response to the medication. Intubated patients had no significant changes in heart rate or
respiratory mechanics, compared to nonintubated patients who had significant responses to the
medication. The authors concluded that aerosol delivery to the lungs is reduced during
mechanical ventilation.
Following the studies demonstrating low delivery of aerosols to the lungs, O’Doherty,
Thomas, Page, Treacher, and Nunan (1992) developed an in vitro model to test the effects
ventilator settings, nebulizer type and volume of fill had on deposition. The system used a Servo
900c mechanical ventilator with heated water bath. At the end of the ETT a filter was placed to
collect and measure the aerosol entering the lung. Lower respiratory rate and increased flow
through the nebulizer improved deposition, most likely due to smaller particle size. Increased fill
volume also improved deposition and ultrasonic nebulizers were shown to provide better
deposition than jet nebulizers. In their in vitro system, the authors were able to achieve a 5-11%
deposition versus 2.9% seen in vitro. Therefore, they conclude that delivery to patients may be
improved by appropriately selecting the methods and parameters during aerosol delivery.
The early studies suggested impaction on the ETT was responsible for low aerosol
deposition in the lungs. To test this theory, Thomas, et al. (1993) administered radiolabeled
saline via jet nebulizer to nine mechanically ventilated patients mechanical ventilation following
open heart surgery. The results showed that only 3.2% of the initial nebulizer dose reached the
respiratory tract, with 1% being deposited on the ETT or trachea. Most of the dose was retained
in the nebulizer unit or connections. The 2.2% lung deposition was consistent with previous
research, but they showed only a small amount was deposited on the ETT. The authors note the
nebulizer produced the most aerosol at the end of inspiration. This aerosol is likely to be carried
out of the circuit through the expiratory limb, bypassing the patient.
11

O’Riordan, Palmer and Smaldone (1994) designed an in vivo system to investigate
aerosol deposition in mechanically ventilated patients. Seven patients were mechanically
ventilated through tracheostomy tubes and administered 2 ml radiolabeled saline via jet
nebulizer. During the nebulizer administration, the humidifier was turned off. The results
showed that 30.6% of the drug was inhaled, 1.8-3.0% was deposited in the tracheostomy tube,
12.6% was exhaled, and 15.3% was deposited in the lungs. Therefore, pulmonary deposition of
the aerosol was relatively high—53% of inhaled particles were deposited in the lung. The
authors conclude that aerosol delivery with mechanical ventilator can be practical with the
proper choice of nebulizer and ventilator, and with the humidification system switched off during
aerosol delivery.
It is important to understand how newer ventilator design—with features such as bias
flow—affects the delivery of aerosols. Miller, Palmer, Shah, and Smaldone (2003) designed a
two-part study to determine the best delivery method for aerosolized medication. First, a
ventilator was used to ventilate a test lung via an ETT. Albuterol was administered via jet
nebulizer placed 12 inches from the wye piece and was sampled at the distal end of the ETT.
The aerosol was given by continuous or breath actuated nebulizer (BAN) with the humidifier on
or off. The test showed that treatment using continuous nebulizers with humidified circuits gave
a 5.7% deposition, while BAN without humidification gave 37.4% deposition. Second, when
comparing the sputum given one hour after aerosolized antibiotics were given to intubated and
mechanically ventilated patients, BAN with no humidification gave a 20 fold increase in
deposition over continuous nebulizers with humidification. This research supported O’Riordan,
et al. (1994), showing that deposition improves with humidification off. Further, it showed that
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in newer ventilators, using breath actuated nebulizers without humidification gives a remarkable
increase in aerosol deposition.
Vibrating Mesh Nebulizers during Mechanical Ventilation
Vibrating mesh nebulizers (VMN) are a novel technology for delivering aerosols. VMNs
use vibrating mesh or plates with apertures to create an aerosol. The aerosols generated by
VMNs have a high fine particle fraction which have been shown to be more effective at
delivering drugs to the respiratory tract (Dhand, 2004). Several studies have recently
investigated the use of VMNs with mechanical ventilation. Ari, Aerabi, and Fink (2010)
examined the effects of various aerosol generation devices at different positions in the ventilator
circuit on aerosol deposition. In vitro, a ventilator was used to deliver albuterol sulfate to a
model lung via by jet nebulizer, VMN, ultrasonic nebulizer or pMDI. Deposition was measured
by spectrophotemetry of a filter placed distal to the ETT. The results showed that the highest
deposition was obtained with VMN placed six inches from the wye piece. Further, deposition
was increased almost two fold through a nonhumidified circuit compared to a humidified circuit.
In fact, with VMN through a nonhumidified circuit, 30.2% of aerosol was delivered to the lungs.
The authors conclude that the delivery device is important for optimizing aerosol delivery during
mechanical ventilation.
In a follow-up study, Ari, et al., (2010) examined the effects of nebulizer type and
position with bias flow on aerosol deposition during mechanical ventilation. This study used a
similar in vitro model to their previous work, with albuterol sulfate delivered via jet nebulizer or
VMN and bias flows of 2 and 5 liters per minute. Results showed that VMN increased aerosol
deposition 2-4 fold over jet nebulizer. Bias flow was shown to influence aerosol deposition.
Contrary to the previous study by Ari, et al (2010) where no bias flow was used, deposition was
13

greatest when the VMN was placed proximal to the ventilator. This study shows that VMNs
deliver higher doses of aerosolized medication than jet nebulizers and that placement of the
VMN is important when using bias flow.
The reports of higher aerosol delivery lead Hart, et al. (2009) to investigate how VMN
affected HMEs used in the ventilator circuit. In an in vitro study, a ventilator was used to
ventilate a test lung with an HME placed at the end of the wye. VMN, jet nebulizer, or
pressurized metered dose inhaler were used to deliver albuterol sulfate and placed between the
HME and ETT. After six treatments were given, the increase in HME weight and resistance was
measured. The results showed that after the treatments the weight of the HME increased by
25.75% with the VMN compared to 16.7% with the jet nebulizer. The VMN also showed a
significant increase in resistance compared to the other aerosol generators. This study
demonstrates how the increased aerosol particle generation of the VMN may lead to
complications when using an HME.
HMEs Designed to Allow Aerosol Delivery (HME-AD)
Published information regarding the performance of HME-ADs is difficult to locate,
however several abstracts were found pertaining to these devices. Branson and Johannigman
(2004) studied the effects of a prototype HME-AD from Thayer Medical. The device had a lever
that in the aerosol configuration allowed aerosol to be delivered through its center, and the HME
configuration diverted the air through the HME portion of the device. Two groups were tested as
described by ISO 9360 lung model for 24 hours; one group was given 0.5ml/5ml albuterol/saline
every 2 hours for the duration and the second group received no albuterol. The authors found
that when turned to the off position the moisture output was similar to currently available HMEs.
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Resistance increased throughout the 24 hours, but there was no statistical significance between
the HME-AD with or without albuterol.
The Circuvent made by DHD is another HME-AD device. When turned to the aerosol
configuration this device allows a separate route for aerosol, bypassing the HME. Brady and
Hess (2004) performed an in vitro test to determine how the HME-AD affects aerosol deposition.
Their design used a mechanical ventilator to deliver tidal volume to a test lung in a circuit at
35°C with 100% relative humidity or a dry circuit. Albuterol was administered via pressurized
metered dose inhaler while the HME-AD was in the aerosol configuration. The results showed
that both the wet circuit and HME-AD significantly reduced aerosol delivery. Compared to a
dry circuit without an HME, the HME-AD decreased aerosol deposition 40%. The authors
concluded that if the HME-AD is used, medication should be doubled to deliver aerosol.
One criticism of the HME-ADs is that the operator may forget to turn the device to the
HME configuration after an aerosol treatment, or may incompletely turn the device to the aerosol
configuration for aerosol delivery. The Humid-Flo by Gibeck is an HME-AD that allows aerosol
to pass through its center in the aerosol configuration, similar to the prototype device by Thayer.
Badescu, Volsko, and Chatburn (2007) tested the effects of aerosol treatments through the HMEAD when the device was not completely placed in the aerosol configuration. The authors tested
for the presence of PEEPi and resistance after a double lung simulator being ventilated in assist
control mode was given six aerosol treatments of normal saline. At the end of the study the
authors did not detect PEEPi nor change in resistance. The authors concluded that even when the
device is not completely in the aerosol configuration, the HME-AD is safe and functional.
With a complete understanding of resistance through an HME, aerosol delivery in
mechanical ventilation, and a survey of the early reports on HME-ADs, the effectiveness of
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HME-ADs can be ascertained. The literature shows that addition of an HME to the mechanical
ventilator circuit does cause an increase in airflow resistance, which is intensified by the addition
of aerosolized medication. Further, aerosol deposition is compromised during mechanical
ventilation. However, techniques such as using VMN, optimal aerosol generator position, and
pausing humidifier during aerosol treatment can be used to improve this deposition. In order for
HME-ADs to be practical, their addition must not significantly diminish the amount aerosol
delivered to the lungs, and must not increase resistance through the HME.
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CHAPTER III
METHODS
Instruments
Lung Model: As shown in Figure 1, the in-vitro lung model of this study consisted of a
rubber test lung and cascade humidifier (Covidian-Puritan Bennett, Boulder, CO) set to deliver
37˚ C and 100% relative humidity which was verified via digital hygrometer/thermometer
(Control Company, Friendswood, TX). The humidifier was attached to an 8.0 mm ID ETT via
an anesthesia filter (Respirgard II filter model 303, Vital Signs, Inc., Totowa, NJ) connected to a
ventilator (Phillips/Respironics, Murrysville, PA) through a standard ventilator circuit
(Allegiance Healthcare Corporation, McGraw Park, IL).

Rubber Test
Lung

Nebulizer
Collecting Filter
HME-AD
ETT

Ventilator
Circuit

370c 100%
Hygrometer/ Thermometer

Hygrometer/ Thermometer
Ventilator

Figure 1. Diagram of lung model and ventilator setup
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Cascade Humidifier

Ventilator Settings: Prior to each experiment the ventilator circuit and test lung were
checked to ensure connection integrity and proper functionality. All calibration tests were
passed successfully. The ventilator settings used during all experiments were as follows: tidal
volume of 450 ml, respiratory rate of 20/min, peak inspiratory flow of 50 L/min, PEEP of 5 cm
H2O, I:E ratio of 1:2, and decelerating flow.
Study Variables: The independent variables of this study were the three HME-AD
placed in the HME or aerosol configuration. Outcome variables include change in airway
resistance and aerosol deposition distal to the ETT.
HME-AD: The three HME-ADs tested in this study include the Circuvent HME/HCH
bypass (Smiths-Medical Keene, NH), Gibeck Humid-Flo™ HME (Hudson RCI, Arlington
Heights, IL), and Airlife bypass HME (Carefusion, San Diego, California). Each HME-AD has
two functional configurations: (1) aerosol (bypassing the HME) and (2) HME.
The Circuvent (Figure 2) requires placement of a standard HME. For this experiment,
the Gibeck Humidvent Filter Light S (Hudson RCI, Arlington Heights, IL) was used. A ring on
the body of the device controls the path the gas takes. Two symbols are located on the ring: an
arrow and a  symbol. To allow aerosol delivery, the ring is twisted until clicked into place
with the arrow pointing towards the tubing and the  lining up with the HME. This is the
aerosol configuration, which directs air through tubing that bypasses the HME. To change to the
HME configuration, the ring is twisted until clicking into place with arrow pointing towards the
HME and  symbol lining up with the tubing. In this configuration, gas is directed through the
HME.
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The Humid-Flo (Figure 2) has a rotatable blue collar that changes the conformation of the
HME-AD. To activate the aerosol configuration, the collar is rotated until “AEROSOL” is
displayed in a white box with block letters which allows aerosol through the center passageway
of the device while bypassing the HME element. The HME configuration is achieved by rotating
the collar until a green box with “HME” is seen. This diverts the incoming gas through the
HME. The collar should be completely rotated to ensure proper delivery of aerosolized
medication or heated and humidified gas.
The Airlife bypass HME (Figure 2) has a lever that controls a gate managing the
direction gas flows through the device. Pushing the lever down until it clicks in place and points
toward the graphic of aerosol particles opens the gate and allows aerosolized medication to flow
straight through the device. This is the aerosol configuration. When the lever is up and pointed
toward the water droplet graphic the gate is closed and gas flows into the HME segment of the
device, which is the HME configuration.

Figure 2. The HME-ADs. A: Circuvent HME/HCH bypass with Gibeck Humidvent Filter Light
S inline. B: Humid-Flo HME. C: Airlife bypass HME.
Data Collection
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Control: Albuterol (2.5 mg/3 mL) was delivered via VMN (Aerogen Solo, Aerogen
Inc., Ireland) placed between the inspiratory limb and wye piece without HME-AD in the circuit
(n=3). Aerosol deposition was measured at the end of each run.
HME-AD: Before testing each HME-AD the point which the HME became saturated
was established by placing the HME-AD in the circuit in the HME configuration and measuring
resistance every five minutes until the resistance stabilized and no further changes occurred. The
Circuvent and Humid-Flo each had no further increase in resistance after 10 minutes in the
humidified ventilator circuit. The Airlife required 20 minutes to plateau. Consequently, each
HME-AD was placed in the circuit in the HME configuration and allowed to plateau according
to these times prior to each test run.
For each experimental run, one HME-AD was placed in the circuit between the wye
piece and ETT. A 90° elbow was placed between the HME-AD and ETT. HME-AD and
collecting filter were positioned superior to the ETT using the natural bend of the ETT to
maintain its inferior position. Aerosol was delivered in a total of three runs (n=3) with HME-AD
in the HME and aerosol configurations. A new HME-AD was used in each run. Airway
resistance and aerosol deposition were measured at the end of each run. This was repeated for
each HME-AD.
Airway Resistance: Airway resistance was measured via the ventilator using the
resident software to determine inspiratory resistance. The values recorded were taken from the
resistance display on the ventilator monitor. Resistance was recorded prior to aerosol treatment
and again at the conclusion of the treatment.
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Aerosol Deposition: Albuterol (2.5 mg/3 mL) was placed in the VMN, which was placed
between the inspiratory limb and the wye piece. Treatments were allowed to proceed until
aerosol was no longer produced. After each treatment the anesthesia filter was removed from the
circuit and soaked with 0.1 N HCl to elute the drug and analyzed via spectrophotometry. The
spectrophotometer (Beckman Instruments, Fullerton, California) was calibrated prior to trials
using holmium oxide filter (Beckman Instruments, Fullerton, California) to determine
wavelength accuracy, and set to zero, using the solvent alone before each analysis. The percent
of drug deposited was evaluated based upon the original dose.
Data Analysis
Data was analyzed using PASW (version 18.0). First, aerosol deposition between the
aerosol and HME configurations of each HME-AD was compared with a series of student t-tests.
Then, differences on aerosol deposition and airway resistance among the HME-ADs were
analyzed using one way analysis of variance (ANOVA). Significance was determined as
p<0.05.
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CHAPTER IV
RESULTS
Airway Resistance
The initial resistance through the HME-ADs in the HME configuration prior to saturation
were as follows: Circuvent—8.62 cm H2O/L/sec, Humid-Flo—8.6 cm H2O/L/sec, and Airlife—
7.71 cm H2O/L/sec. The mean and standard deviation values attained before and after the
experimental runs are shown in Table 1. Airway resistance significantly increased after the
albuterol was administered in each case.
Table 1
Mean airway resistance (cm H2O/L/sec) and standard deviation before and after albuterol
treatment using Circuvent, Humid-Flo, and Airlife.
Circuvent
Aerosol

Humid-Flo

HME

Aerosol

Airlife

HME

Aerosol

HME

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Mean

7.96

9.16

9.49

10.46

7.71

9.42

8.53

9.06

7.3

8.92

8.03

9.06

SD

0.15

0.27

0.07

0.12

0.06

0.14

0.07

0.02

0.29 0.39

0.14

0.19

Airway Resistance in the Aerosol Configuration: The results for airway resistance in
the aerosol configuration are shown in Figure 3. Prior to aerosol administration, resistance was
significantly different between Circuvent and Airlife (p=.009). There were no significant
differences between Circuvent and Humid-Flo (p=.389), or Airlife and Humid-Flo (p=.096).
After the albuterol treatment there were no statistically significant differences in resistance
between any groups (p>0.05).
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Mean Airway Resistance (cm H2O/ L/ sec) in the Aerosol
Configuration Prior to and After Albuterol Treatment
12
10

*

*

*

8
6

Prior to Treatment
After Treatment

4
2
0
Circuvent

Humid-Flo

Airlife

Figure 3. Airway resistance (cm H2O/L/sec) in the aerosol configuration prior to and after
aerosol administration. * indicates statistical significance (p<0.05).
Airway Resistance in the HME Configuration: The results for airway resistance in the
HME configuration are shown in Figure 4. Prior to albuterol treatment, the differences between
each HME-AD were statistically significant. The Circuvent had the highest resistance with 9.49
± 0.06 cm H2O/L/sec, and the Airlife had the least resistance with 8.02 ± 0.13 cm H2O/L/sec.
Following the treatment, the Circuvent continued to give the highest airway resistance with
10.46 ± 0.11 cm H2O/L/min. Resistance in the Airlife increased to 9.06 ± 0.19 cm H2O/L/sec
and the Humid-Flo increased to 9.06 ± 0.02 cm H2O/L/sec following the treatment. These values
were not statistically significant (p=.999).
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Mean Airway Resistance (cm H2O/ L/ sec) in the HME
Configuration Prior to and After Albuterol Treatment
*

*
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*
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*

*

*

*

*

8
6

Prior to Treatment
After Treatment

4
2
0
Circuvent

Humid-Flo

Airlife

Figure 4. Mean airway resistance (cm H2O/L/sec) in the HME configuration prior to and after
albuterol treatment. * indicates statistical significance (p<0.05)
Aerosol Deposition
The percentages of mean and standard deviations attained for aerosol deposition after the
experimental runs are presented in Table 2. Aerosol deposition was significantly different
between the aerosol configuration and HME configuration in the Circuvent (p=.005) and Airlife
(p=.002). In the Humid-Flo, there was no significant difference in aerosol deposition between
the aerosol and HME configurations (p=.078).

24

Table 2
Mean and standard deviations (SD) of inhaled drug mass percent in both aerosol and HME
configurations using the Circuvent, Humid-Flo, and Airlife. *indicates statistical significance
(p<0.05).
Circuvent*

Humid-Flo

Airlife*

Control
Aerosol

HME

Aerosol

HME

Aerosol

HME

Mean

16.00%

11.86%

4.00%

11.22%

10.56%

13.69%

10.03%

SD

1.57%

0.85%

0.16%

0.40%

0.06%

0.13%

0.29%

Aerosol Deposition in the Aerosol Configuration: Aerosol deposition in the aerosol
configuration is shown in Figure 5. Control had the highest mean albuterol deposition at 16 ±
1.57% followed by the Airlife with 13.69 ± 0.13%. The difference between control and Airlife
was not significant (p=.084). Both Circuvent (p=.004) and Humid-Flo (p=.002) delivered
significantly less aerosol compared to control. The differences among the HME-ADs were not
significantly different (p>0.05).
Aerosol Deposition in the HME Configuration: Aerosol deposition in the HME
configuration is shown in Figure 5. The Circuvent gave the least deposition with 4.00 ± 0.16%.
Airlife and Humid-Flo gave 10.03 ± 0.29% and 10.56 ± 0.06% respectively. The differences in
aerosol deposition between HME-ADs in the HME configuration were all statistically
significant.
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Comparison of aerosol deposition between aerosol and HME
configurations, using the Circuvent, Humid-Flo, and Airlife
20.00%
18.00%

*

*

*

*

*

16.00%

*

*

14.00%
12.00%
10.00%

Aerosol Configuration
HMEConfiguration

8.00%
6.00%
4.00%
2.00%
0.00%
Control

Circuvent

Humid-Flo

Airlife

Figure 5. Comparison of aerosol deposition between aerosol and HME configurations, using
the Circuvent, Humid-Flo, and Airlife. * indicates statistical significance (p<0.05).
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CHAPTER V
DISCUSSION
Novel devices for allowing aerosol delivery while using an HME to heat and humidify
the patient’s airway are advantageous and may improve cost effectiveness. However, the
clinician should be aware of the implications of these devices when used. Of particular
importance is how these devices affect the aerosol deposition of the medication that is being
delivered since it is paramount that the patient receives effective doses. The airway resistance is
also important to consider ensuring PEEPi and work of breathing are not increased. The purpose
of this study was to determine the effects that three commercially available HME-ADs have on
aerosol deposition and airway resistance. After running the tests and analysis of the data, it is
noted the design of HME-ADs impact both airway resistance and aerosol deposition. The
following discussion will analyze the observations made during the study, evaluate how this
study compares with the available literature, and define the limitations of the study.
Observations
The most surprising finding of this study was aerosol deposition in the HME
configuration. The amount of deposition in the HME configuration is a function of the ability of
the HME to filter out aerosol particles. This was the case in the Circuvent where the HME
configuration significantly reduced aerosol deposition to 4.0 ± 0.16%. The use of a conventional
HME had the effect of removing most of the aerosol particles. However, there was no
significant difference between the aerosol and HME configurations for the Humid-Flo.
Examining the Humid-Flo revealed relatively large holes visible in the HME portion of the
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device. These holes are substantial enough to allow small aerosol particles, which would be
most likely to enter the airway, to pass through the HME and allow similar aerosol deposition in
both configurations. In the Airlife, deposition was significantly decreased but only by 3.66%,
allowing 10.03 ± 0.29% deposition. This higher than expected deposition could be due to the
size of the holes in the HME. Another explanation is that the area adjacent to the “gate” is not
sealed, and allows aerosol particles to enter the ETT without passing through the HME portion of
the device. Whatever the cause, the fact that aerosol particles are able to bypass the HME leads
to the possibility that gas from the ventilator may also bypass the HME and give inadequate heat
and humidity to the patient’s airway. The efficiency of the HME portion of these devices is
beyond the scope of this study, but is a good topic for future research.
In the HME configuration prior to aerosol administration, each HME-AD had a
significantly different airway resistance. This disparity is due to variations in the design of the
HME within the devices. The Circuvent had the highest resistance. Since the Circuvent requires
placement of a standalone HME, this resistance is more a function of the HME used (Gibeck
Humidvent Filter Light S, Hudson RCI, Arlington Heights, IL) than a reflection of the Circuvent.
After the aerosol treatment, the Circuvent again had a higher resistance, and the resistance
through the Airlife and Humid-Flo were no longer statistically significant. One possible
explanation is that the albuterol being delivered collected in the HME and caused increased
resistance.
The highest deposition was seen in the control group. In the Airlife with the aerosol
configuration, there was no significant difference in aerosol deposition compared to control,
while the Humid-Flo and Circuvent had significantly less deposition. This change in deposition
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is likely due to the design of these HME-ADs. In the Humid-Flo, the lumen is reduced by tabs in
the center of the device used to direct gas, which increases aerosol impacting against the
apparatus and reduces the amount of medication delivered to the airway. In the Circuvent, gas is
redirected through a semicircular piece of corrugated tubing. This change in direction also leads
to impaction. In the Airlife, the mechanism of switching to the aerosol configuration involves
moving a “gate” out of the path of the gas. Therefore, little impaction is expected. The direct
path allows for greater amounts of aerosol particles to enter the ETT and gives similar deposition
compared to control.
Implications
Based on the evidence, the Airlife gives the highest aerosol deposition, which was not
significantly different from the control. Further, airway resistance associated with the Airlife
was the lowest before treatment in both configurations. However, after one treatment in the
HME configuration, its resistance was similar to the Humid-Flo. This increase may become
substantial after more treatments are delivered in this configuration. The resistance of the
Circuvent is largely influenced by the HME used. Choosing an HME with lower resistance
would be advisable for all patients, especially those with a potential for air trapping and
difficulty weaning from mechanical ventilation. These experiments show that resistance is not
increased by delivering aerosol to the patient in the HME configuration compared to the aerosol
configuration. Therefore, a caregiver forgetting to turn the device to the aerosol configuration
will not increase airway resistance.
The fact that the albuterol delivered to the airway was not affected by configuration in the
Humid-Flo and only affected minimally in the Airlife is noteworthy. It appears that these
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devices are always in a semi-bypass configuration. Thus, if a healthcare provider forgot to
switch the device configuration prior to delivering an albuterol treatment, the patient would still
receive the drug. The similar airway resistance and lack of variation of aerosol deposition
between the aerosol and HME configurations raises the question of the effectiveness of the HME
portion of the devices. If the HME portion is effective, then the aerosol configuration may not
be necessary with the Humid-Flo or Airlife.
Cost is important for hospitals considering using these devices in their facility. The
suggested retail prices per unit are as follows: Circuvent—$6.00, Humid-Flo—$10.14, and
Airlife—$6.04. These prices indicate the Circuvent is the cheapest. However, the Circuvent
also requires an external HME. In this experiment, the Gibeck Humidvent Filter Light S was
utilized. The list price of this HME is $7.04, which brings the total cost of using the Circuvent to
$13.04. However, less expensive HMEs are available. Some HMEs cost as little as $2.05. With
this price, the total cost of the Circuvent is less than the Humid-Flo. Nevertheless, the Airlife is
still the least expensive HME-AD and most cost-efficient assuming it provides adequate heat and
humidity.
Comparisons with Literature
Since there was only a limited number of articles on HME-ADs available in the literature,
on two studies will be used for comparison. First, Brady and Hess tested the Circuvent using the
aerosol configuration in 2004. Their study found that when using a pressurized metered dose
inhaler, aerosol was reduced 40% from control. In this study, the Circuvent reduced aerosol
deposition by 26% compared to control, and overall the HME-ADs reduced aerosol deposition
by 15-30% compared to control. The higher numbers found in this experiment were due to the
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use of VMN, which has a greater efficiency. Badescu, et al. (2007) found that during aerosol
delivery with the Humid-Flo incompletely turned to the aerosol configuration the resistance did
not increase significantly. Similarly, in this study after one treatment with albuterol, the
resistance did not increase further than control in the Humid-Flo or any of the HME-ADs.
Limitations
This study had four limitations. First, this was an in-vitro study. While our study used a
homogenous test lung, human subjects would have heterogeneous lungs with varying lung
mechanics. Second, only one albuterol treatment was given per HME-AD. Clinically, these
devices are used for 24 hours or longer and patients would generally receive albuterol treatments
every four hours. Thus, the HME-AD would have more aerosol passing through it than tested,
which could lead to increases in resistance beyond what was found in this study. Third, no
assessment was made to determine the effectiveness of the HME portion of the HME-ADs for
providing adequate temperature and humidification, this would be critical to determine how the
partial bypass of the HME impacts primary function. Finally, only one type of aerosol generator
was used in this study. The VMN was chosen based on its low residual volume and high percent
of dose nebulized and previous reports associating that output volume with changes of resistance
with the HME. However, jet nebulizers and pressurized metered dose inhalers are more
prevalent clinically. Therefore, data on aerosol deposition and airway resistance with these
devices would be relevant.
These limitations elicit questions for response at a later time. Does an in-vivo model
affect airway resistance and aerosol differently than the in-vitro model used? Do airway
resistance and aerosol deposition change as subsequent albuterol treatments are given? How
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effective are HME-ADs at providing heat and humidity during mechanical ventilation? How are
airway resistance and aerosol deposition affected when different types of aerosol generators are
used?
Conclusions
Aerosol delivery and airway resistance with each HME-AD differ in simulated
mechanically ventilated patients. The design and composition is responsible for the variation in
resistance and aerosol deposition. The best choice is an HME-AD that allows for the greatest
aerosol deposition with the least increase in airway resistance, while providing the best
humidification of the airway. Further studies are needed to determine the effectiveness of these
devices over time and with different aerosol generating devices.
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